Concepedia

Yuqi Kang

YK

Statistics

Publications

13

Citations

1.3K

H-Index

12

Active since

2018

Affiliations

University of Washington(Current)

University of California San Diego

Fred Hutch Cancer Center

First People's Hospital of Chongqing

Tongji Hospital

Yuqi Kang is an author at University of Washington specializing in oncology, life sciences, and medicine.

Publications per year

2018–2023

13

Publications

13

ALKBH5 regulates anti–PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment

Na Li, Yuqi Kang, Lingling Wang et al. · Proceedings of the National Academy of Sciences · 2020 · 596 citations · Full text

Medicine, Cancer Biology, Oncology +17

m6A RNA methyltransferases METTL3/14 regulate immune responses to anti‐PD‐1 therapy

Lingling Wang, Hui Hui, Kriti Agrawal et al. · The EMBO Journal · 2020 · 419 citations · Full text

Life Sciences, Genetics, Immunology +9

HIV reprograms host m6Am RNA methylome by viral Vpr protein-mediated degradation of PCIF1

Qiong Zhang, Yuqi Kang, Shaobo Wang et al. · Nature Communications · 2021 · 69 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +15

Fatty-acid receptor CD36 functions as a hydrogen sulfide-targeted receptor with its Cys333-Cys272 disulfide bond serving as a specific molecular switch to accelerate gastric cancer metastasis

Rui Wang, Bei‐Bei Tao, Qilin Fan et al. · EBioMedicine · 2019 · 50 citations · Full text

Medicine, Cancer Biology, Oncology +15

Deep neural network modeling identifies biomarkers of response to immune-checkpoint therapy

Yuqi Kang, Siddharth Vijay, Taranjit S. Gujral · iScience · 2022 · 32 citations · Full text

Life Sciences, Bioinformatics, Oncology +17

1–5 of 13